Clinical Trial Supply · Africa

Africa is not an
execution problem. It is a decision problem.

Rêve Solutions helps pharmaceutical and biotech sponsors make structured, defensible decisions on clinical trial expansion into African corridors — before operational commitments are made.

Change · Your · Vision · Angle
19%
Of world population
lives in Africa
25%+
Of global disease
burden on the continent
15 yrs
CTS experience across
African corridors
5 layers
In the CCIM™
decision framework

Most sponsors recognise the scientific case for Africa. The hesitation is rarely scientific.

“Africa is not an execution problem waiting to be solved. It is a decision problem waiting to be structured.” — The Rêve Solutions Principle

Africa represents 19% of the world's population and over 25% of the global disease burden, with treatment-naive patient pools and indication-aligned disease profiles.

Yet most sponsors hesitate. Not because the science is unclear — but because three operational uncertainties remain unaddressed before any commitment is made.

01
Clinical trial supply reliability
02
Governance under deviation
03
Unclear strategic ROI

The CCIM™ Framework

Country-Contextualised IMP Management. A proprietary, five-layer decision tool that assesses readiness — from program sensitivity to strategic ROI — and produces a Go/No-Go Decision Pack before any operational commitment is made.

We sit at the decision layer
above CRO execution and logistics vendors.

Engagement 01

Expansion Decision Packs

Structured Go / Conditional Go / No-Go assessments for sponsor leadership, built on CCIM™. The evidence base for a defensible expansion commitment.

Engagement 02

Corridor Intelligence

Independent assessment of specific African corridors — customs, depots, last-mile, governance — based on direct primary-source audits, not desk research.

Engagement 03

Governance Design

ICH E6(R3)-aligned oversight structures, MTTD frameworks, and escalation protocols for sponsors operating in emerging-market corridors.

Révérien Uwacu speaking at a clinical trial supply industry forum
Révérien Uwacu · CTS Europe · Industry forum keynote

The decision layer needs a different kind of advisor.

Révérien Uwacu is the Founder & CEO of Rêve Solutions Consulting and the creator of the CCIM™ framework. Over fifteen years in clinical trial supply chain across European and African corridors — including senior roles in global pharma — shape how Rêve approaches sponsor decisions.

Rigorously. Operationally. With primary-source corridor intelligence rather than secondary research.

He also chairs the RÊVE Diversity & Trials Taskforce — a six-country expert group producing a Strategic Framework & Operational Playbook on Diversity & Inclusion in Clinical Trials, publishing November 2026.

Based
Belgium · Rwanda
Languages
English · French
IP Custodian
CCIM™ Framework
Speaking
CTS Forums · GCSG · International circuit

An active voice on the international CTS circuit.

Révérien speaks regularly at the leading clinical trial supply forums in Europe and globally — including CTS Forums, GCSG, and World BI — introducing the CCIM™ framework to sponsor, CRO, and 3PL audiences.

May 2026
16th Annual Clinical Trial Supply Forum, Amsterdam
"Beyond Feasibility Checklists: What It Actually Takes to Run a Clinical Trial in Africa"
Co-presentation · Shionogi Europe
April 2026
Clinical Supply Leader · Life Science Connect
"Expanding Clinical Trials in Africa Without Disruption"
Featured Article
2025
Clinical Trial Supply Forum, Brussels
Speaker
2025
GCSG, Budapest
Speaker
2024
World BI · 27th Clinical Trials Innovation Programme
Presenter

Ready to change your vision angle on Africa expansion?

We partner with sponsors at the decision layer — providing the regulatory intelligence, corridor expertise, governance design, and strategic ROI analysis that turns Africa from a question mark into a confident strategic commitment.

Révérien Uwacu
Founder & CEO
info@reve-solutions.com +32 479 12 68 74 LinkedIn →